Page last updated: 2024-12-05

1-phenethylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Phenethylamine is a naturally occurring organic compound that serves as a building block for several neurotransmitters, including dopamine, norepinephrine, and epinephrine. It is also a precursor to amphetamines, which are potent stimulants. 1-Phenethylamine is found in trace amounts in the human brain and has been implicated in a variety of psychological and physiological effects. Research on 1-Phenethylamine is ongoing, as its potential role in mood disorders, cognition, and neurodegenerative diseases continues to be investigated.'

1-phenethylamine: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-phenylethylamine : A phenylethylamine that is ethylamine substituted by a phenyl group at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7408
CHEMBL ID278059
CHEBI ID670
SCHEMBL ID830
SCHEMBL ID4701869
MeSH IDM0103139

Synonyms (146)

Synonym
.alpha.-methylbenzylamine
benzylamine, .alpha.-methyl-
wln: 1m1r
nsc8391
nsc-8391
benzenemethaneamine, .alpha.-methyl-
98-84-0
.alpha.-phenethylamine
.alpha.-phenylethylamine
ethylamine, 1-phenyl-
ethanamine, 1-phenyl-
1-amino-1-phenylethane
benzenemethanamine, .alpha.-methyl-
618-36-0
CHEBI:670 ,
alpha-aminoethylbenzene
1-phenethylamine
alpha-methylbenzenemethanamine
(r)-.alpha.-methylbenzenemethanamine
benzenemethanamine, .alpha.-methyl-, (.+/-.)-
benzylamine, .alpha.-methyl-, (.+/-.)-
benzenemethanamine, .alpha.-methyl-, (s)-
(s)-.alpha.-methylbenzenemethanamine
benzenemethanamine, .alpha.-methyl-, (r)-
1-phenylethanamine
alpha-methylbenzylamine
C02455
alpha-phenylethylamine
1-phenylethylamine
alpha-methylbenzylamine, 99%
STK397443
1-phenyl-ethylamine
CHEMBL278059 ,
FT-0658781
dl-1-phenylethylamine
dl-alpha-methylbenzylamine
M0165
bdbm50023171
AKOS000119070
1-phenyl-ethyl-amine
a-methylbenzylamine
nsc 8391
sumine 2079
benzene, (1-amino-ethyl)-
benzenemethaneamine, alpha-methyl-
einecs 202-706-6
hsdb 2742
ai3-03116
einecs 210-545-8
ec 210-545-8
unii-hz9dm6b2mt
alpha-phenethylamine
1-fenylethylamin
benzenemethanamine, alpha-methyl-
1-fenylethylamin [czech]
hz9dm6b2mt ,
benzylamine, alpha-methyl-
a-phenylethylamine
FT-0601072
FT-0604486
PS-4601
AM20060838
(rs)-.alpha.-methylbenzylamine
(1-aminoethyl)benzene
(+/-)-.alpha.-phenethylamine
(+/-)-.alpha.-phenylethylamine
.alpha.-aminoethylbenzene
benzylamine, .alpha.-methyl-, dl-
1-phenethylamine [hsdb]
.alpha.-methylbenzenemethanamine
(rs)-1-phenylethylamine
(r,s)-.alpha. methylbenzylamine
.alpha.-methylbenzylamine [mi]
dl-.alpha.-methylbenzylamine
AKOS016039387
SCHEMBL830
(s)-(-)-.alpha.-methylbenzylamine
1-phenylethan-1-amine
racemic 1-phenylethylamine
alpha-methylbenzyl amine
(-)-alpha-methylbenzenemethanamine
(-) alpha methyl benzyl amine
(-)-1-phenylethylamine
(+)-1-phenylethylamine
racemic alpha-methylbenzylamine
(+)-alpha-methylbenzylamine
(+)-alpha-methyl-benzylamine
a-methylbenzenemethanamine
(+/-)-1-(phenyl)ethylamine
(1-phenylethyl)amine
(+)-alpha-methyl benzyl amine
1(r,s)-phenylethylamine
(+/-)-1-phenyl-ethanamine
(rs)-alpha-methylbenzylamine
racemic 1-phenylethanamine
(+/-)-alpha-methylbenzylamine
(+/-)-1-phenylethanamine
alpha-methylbezylamine
(s)-alpha-methyl benzylamine
(-)-alpha-phenylethylamine
(-) alpha-methyl-benzylamine
(-)-alpha-methylbenzylamine
(-)alpha-phenylethylamine
1-phenyl ethylamine
(s)-(-)-a-methyl-benzylamine
(-)-alpha-methyl-benzylamine
dl-1-phenylethyl amine
rac-1-phenylethanamine
l-phenylethylamine
phenylethan-1-amine
alpha-methyl-benzylamine
(+) alpha-methylbenzylamine
(+/-)-1-phenylethylamine
racemic alpha-methyl-benzenemethanamine
(+/-)-1-phenyl-ethylamine
alpha-methyl benzyl amine
1-phenylethyl amine
(+)1-phenylethan-1-amine
SCHEMBL4701869
1-phenylethanamine #
l-(-)-.alpha.-phenylethylamine
(-)-.alpha.-phenethylamine
l(-)-.alpha.-methylbenzylamine
W-105090
timepidiumbromide
F0798-0597
mfcd00008069
a-phenethylamine
1-phenyl-1-ethanamine
CS-W013564
DTXSID40862301
Q3560549
dl-1-phenethylamine
n-fmoc-amino-4-ketocyclohexylcarboxylicacid
dl-alpha-phenylethylamine
a-aminoethylbenzene
BCP32849
(s)-1-phenylethanamine;(1s)-1-phenylethanamine
D77753
alpha-methyl benzylamine
dl-|a-methylbenzylamine dl-|a-phenylethylamine
EN300-17925
AS-80972
dl-a-methylbenzyla
(+/-)- alpha -methylbenzylamine
Z57102377
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenylethylamine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)Ki424.00000.00312.329310.0000AID145544; AID145546; AID155306; AID156056
Phenylethanolamine N-methyltransferaseHomo sapiens (human)Ki830.00000.00161.35296.9000AID155320
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (3)

Processvia Protein(s)Taxonomy
methylationPhenylethanolamine N-methyltransferaseBos taurus (cattle)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseBos taurus (cattle)
methylationPhenylethanolamine N-methyltransferaseHomo sapiens (human)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseHomo sapiens (human)
catecholamine biosynthetic processPhenylethanolamine N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseBos taurus (cattle)
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseHomo sapiens (human)
protein bindingPhenylethanolamine N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
cytosolPhenylethanolamine N-methyltransferaseHomo sapiens (human)
cytosolPhenylethanolamine N-methyltransferaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID156056In vitro inhibition of compound towards phenylethanolamine N-methyltransferase(PNMT) isolated from bovine adrenal glands1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Conformational preference for the binding of biaryl substrates and inhibitors to the active site of phenylethanolamine N-methyltransferase.
AID155306Inhibitory constant against bovine phenylethanolamine N-methyl-transferase2001Bioorganic & medicinal chemistry letters, Jun-18, Volume: 11, Issue:12
Phenylethanolamine N-methyltransferase kinetics: bovine versus recombinant human enzyme.
AID155320Inhibitory constant against human phenylethanolamine N-methyl-transferase over-expressed in Escherichia coli2001Bioorganic & medicinal chemistry letters, Jun-18, Volume: 11, Issue:12
Phenylethanolamine N-methyltransferase kinetics: bovine versus recombinant human enzyme.
AID145543Inhibitory activity against Norepinephrine N-methyl-transferase of bovine adrenal glands1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Importance of the aromatic ring in adrenergic amines. 7. Comparison of the stereoselectivity of norepinephrine N-methyltransferase for aromatic vs. nonaromatic substrates and inhibitors.
AID155337Ki ratio of human versus bovine phenylethanolamine N-methyl-transferase2001Bioorganic & medicinal chemistry letters, Jun-18, Volume: 11, Issue:12
Phenylethanolamine N-methyltransferase kinetics: bovine versus recombinant human enzyme.
AID145546The inhibitory constant(Ki) value for Norepinephrine N-methyl-transferase was calculated1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Directional probes of the hydrophobic component of the aromatic ring binding site of norepinephrine N-methyltransferase.
AID145544Inhibitory activity against bovine adrenal norepinephrine N-methyl-transferase was determined1982Journal of medicinal chemistry, Oct, Volume: 25, Issue:10
Probes of the active site of norepinephrine N-methyltransferase: effect of hydrophobic and hydrophilic interactions on side-chain binding of amphetamine and alpha-methylbenzylamine.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (75)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (17.33)18.7374
1990's4 (5.33)18.2507
2000's31 (41.33)29.6817
2010's20 (26.67)24.3611
2020's7 (9.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.60 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index65.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.60%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other75 (97.40%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]